Foto del docente

Pier Paolo Piccaluga

Professore associato

Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale

Settore scientifico disciplinare: MED/08 ANATOMIA PATOLOGICA

Pubblicazioni

vai alle Pubblicazioni

Pubblicazioni antecedenti il 2004

Pubblicazioni a stampa su riviste internazionali con Impact Factor
1: Visani G, Sapienza MR, Isidori A, Tripodo C, Laginestra MA, Righi S, Sagramoso
Sacchetti CA, Gazzola A, Mannu C, Rossi M, De Nictolis M, Valentini M, Donati M,
Emiliani R, Alesiani F, Paolini S, Finelli C, Pileri SA, Piccaluga PP. SNPs Array
Karyotyping Reveals a Novel Recurrent 20p13 Amplification in Primary
Myelofibrosis. PLoS One. 2011;6(11):e27560. Epub 2011 Nov 14. PubMed PMID:
22110671; PubMed Central PMCID: PMC3215741.


2: Pileri SA, Agostinelli C, Bacci F, Sabattini E, Sagramoso C, Falini B,
Piccaluga PP. Pathobiology of ALK-negative anaplastic large cell lymphoma.
Pediatr Rep. 2011 Jun 22;3 Suppl 2:e5. PubMed PMID: 22053281; PubMed Central
PMCID: PMC3206530.


3: Agostinelli C, Hartmann S, Klapper W, Korkolopoulou P, Righi S, Marafioti T,
Piccaluga PP, Patsouris E, Hansmann ML, Lennert K, Pileri SA. Peripheral T cell
lymphomas with follicular T helper phenotype: a new basket or a distinct entity?
Revising Karl Lennert's personal archive. Histopathology. 2011 Oct;59(4):679-91.
doi: 10.1111/j.1365-2559.2011.03981.x. PubMed PMID: 22014049.


4: Ciccone M, Agostinelli C, Rigolin GM, Piccaluga PP, Cavazzini F, Righi S,
Sista MT, Sofritti O, Rizzotto L, Sabattini E, Fioritoni G, Falorio S, Stelitano
C, Olivieri A, Attolico I, Brugiatelli M, Zinzani PL, Saccenti E, Capello D,
Negrini M, Cuneo A, Pileri S. Proliferation centers in chronic lymphocytic
leukemia: correlation with cytogenetic and clinicobiological features in
consecutive patients analyzed on tissue microarrays. Leukemia. 2011 Sep 23. doi:
10.1038/leu.2011.247. [Epub ahead of print] PubMed PMID: 21941366.


5: Roncolato F, Gazzola A, Zinzani PL, Pileri SA, Piccaluga PP. Targeted
molecular therapy in peripheral T-cell lymphomas. Expert Rev Hematol. 2011
Oct;4(5):551-62. PubMed PMID: 21939422.


6: Piccaluga PP, Gazzola A, Agostinelli C, Bacci F, Sabattini E, Pileri SA.
Pathobiology of Epstein-Barr virus-driven peripheral T-cell lymphomas. Semin
Diagn Pathol. 2011 Aug;28(3):234-44. Review. PubMed PMID: 21850988.


7: Pileri A Jr, Patrizi A, Agostinelli C, Neri I, Sabattini E, Bacci F, Piccaluga
PP, Pimpinelli N, Pileri SA. Primary cutaneous lymphomas: a reprisal. Semin Diagn
Pathol. 2011 Aug;28(3):214-33. Review. PubMed PMID: 21850987.


8: Inghirami G, Pileri SA; European T-Cell Lymphoma Study Group. Anaplastic
large-cell lymphoma. Semin Diagn Pathol. 2011 Aug;28(3):190-201. Review. PubMed
PMID: 21850985.


9: Paolini S, Gazzola A, Sabattini E, Bacci F, Pileri S, Piccaluga PP.
Pathobiology of acute lymphoblastic leukemia. Semin Diagn Pathol. 2011
May;28(2):124-34. Review. PubMed PMID: 21842698.


10: Pileri SA, Agostinelli C, Sabattini E, Bacci F, Sagramoso C, Pileri A Jr,
Falini B, Piccaluga PP. Lymphoma classification: the quiet after the storm. Semin
Diagn Pathol. 2011 May;28(2):113-23. Review. PubMed PMID: 21842697.


11: Gazzola A, Sabattini E, Mannu C, Bacci F, Sagramoso Sacchetti CA, Artioli P,
Chilli L, Da Pozzo G, Piccioli M, Falini B, Pileri SA, Piccaluga PP. Partial
nodal involvement by marginal zone lymphoma. Use of IGK gene rearrangement
analysis in diagnostic work-up. Pathologica. 2011 Feb;103(1):14-8. PubMed PMID:
21837920.


12: Piccaluga PP, Agostinelli C, Tripodo C, Gazzola A, Bacci F, Sabattini E,
Pileri SA; European T‑cell Lymphoma Study Group. Peripheral T-cell lymphoma
classification: the matter of cellular derivation. Expert Rev Hematol. 2011
Aug;4(4):415-25. Review. PubMed PMID: 21801133.


13: Zinzani PL, Piccaluga PP. Primary mediastinal DLBCL: evolving biologic
understanding and therapeutic strategies. Curr Oncol Rep. 2011 Oct;13(5):407-15.
doi: 10.1007/s11912-011-0189-5. Review. PubMed PMID: 21789543.


14: Piccaluga PP, Pileri SA, Agostinelli C, Klapper W, Lennert K. Follicular
lymphoma: still Six characters in search of an author? Leuk Lymphoma. 2011
Sep;52(9):1655-67. Epub 2011 Jun 10. Review. PubMed PMID: 21657965.


15: Tabanelli V, Agostinelli C, Sabattini E, Gazzola A, Bacci F, Capria S, Mannu
C, Righi S, Sista MT, Meloni G, Pileri SA, Piccaluga PP. Systemic
Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a
22-year-old Caucasian man: A case report and review of the literature. J Med Case
Reports. 2011 Jun 7;5:218. PubMed PMID: 21649898; PubMed Central PMCID:
PMC3130681.


16: Barreca A, Lasorsa E, Riera L, Machiorlatti R, Piva R, Ponzoni M, Kwee I,
Bertoni F, Piccaluga PP, Pileri SA, Inghirami G; European T-Cell Lymphoma Study
Group. Anaplastic lymphoma kinase in human cancer. J Mol Endocrinol. 2011 Jul
4;47(1):R11-23. Print 2011. Review. PubMed PMID: 21502284.


17: Tripodo C, Sangaletti S, Piccaluga PP, Prakash S, Franco G, Borrello I, Orazi
A, Colombo MP, Pileri SA. The bone marrow stroma in hematological neoplasms--a
guilty bystander. Nat Rev Clin Oncol. 2011 Mar 29;8(8):456-66. doi:
10.1038/nrclinonc.2011.31. Review. PubMed PMID: 21448151.


18: Piccaluga PP, Gazzola A, Mannu C, Agostinelli C, Bacci F, Sabattini E,
Sagramoso C, Piva R, Roncolato F, Inghirami G, Pileri SA. Pathobiology of
anaplastic large cell lymphoma. Adv Hematol. 2010:345053. Epub 2011 Feb 6. PubMed
PMID: 21331150; PubMed Central PMCID: PMC3038421.


19: Tumwine LK, Lalitha R, Agostinelli C, Luzige S, Orem J, Piccaluga PP, Osuwat
LO, Pileri SA. Primary effusion lymphoma associated with Human Herpes Virus-8 and
Epstein Barr virus in an HIV-infected woman from Kampala, Uganda: a case report.
J Med Case Reports. 2011 Feb 14;5(1):60. PubMed PMID: 21320326; PubMed Central
PMCID: PMC3048476.


20: Piccaluga PP, Agostinelli C, Gazzola A, Tripodo C, Bacci F, Sabattini E,
Sista MT, Mannu C, Sapienza MR, Rossi M, Laginestra MA, Sagramoso-Sacchetti CA,
Righi S, Pileri SA. Pathobiology of hodgkin lymphoma. Adv Hematol.
2011;2011:920898. Epub 2010 Dec 22. PubMed PMID: 21253495; PubMed Central PMCID:
PMC3021869.


21: Piccaluga PP, De Falco G, Kustagi M, Gazzola A, Agostinelli C, Tripodo C,
Leucci E, Onnis A, Astolfi A, Sapienza MR, Bellan C, Lazzi S, Tumwine L, Mawanda
M, Ogwang M, Calbi V, Formica S, Califano A, Pileri SA, Leoncini L. Gene
expression analysis uncovers similarity and differences among Burkitt lymphoma
subtypes. Blood. 2011 Mar 31;117(13):3596-608. Epub 2011 Jan 18. PubMed PMID:
21245480.


22: Piccaluga PP, Sapienza MR, Agostinelli C, Sagramoso C, Mannu C, Sabattini E,
Zinzani PL, Pileri SA. Biology and treatment of follicular lymphoma. Expert Rev
Hematol. 2009 Oct;2(5):533-47. Review. PubMed PMID: 21083019.


23: Piccaluga PP, Arpinati M, Candoni A, Laterza C, Paolini S, Gazzola A,
Sabattini E, Visani G, Pileri SA. Surface antigens analysis reveals significant
expression of candidate targets for immunotherapy in adult acute lymphoid
leukemia. Leuk Lymphoma. 2011 Feb;52(2):325-7. Epub 2010 Nov 15. PubMed PMID:
21077738.


24: Visani G, Breccia M, Gozzini A, Specchia G, Montefusco E, Morra E, Annunziata
M, Camera A, Cavazzini F, Stagno F, Pregno P, Usala E, Santini V, Piccaluga PP,
Isidori A. Dasatinib, even at low doses, is an effective second-line therapy for
chronic myeloid leukemia patients resistant or intolerant to imatinib. Results
from a real life-based Italian multicenter retrospective study on 114 patients.
Am J Hematol. 2010 Dec;85(12):960-3. PubMed PMID: 21069865.


25: Gazzola A, Sista MT, Agostinelli C, Righi S, Sapienza MR, Mannu C, Rossi M,
Bacci F, Sabattini E, Went P, Zinzani PL, Pileri SA, Piccaluga PP. CDKN1B/p27
expression in peripheral T cell lymphoma not otherwise specified. J Clin Pathol.
2011 Jan;64(1):83-7. Epub 2010 Nov 2. PubMed PMID: 21045237.


26: Agostinelli C, Sabattini E, Gjørret JO, Righi S, Rossi M, Mancini M,
Piccaluga PP, Bacci F, Marafioti T, Bettini G, Falini B, Pileri SA.
Characterization of a new monoclonal antibody against PAX5/BASP in 1525
paraffin-embedded human and animal tissue samples. Appl Immunohistochem Mol
Morphol. 2010 Dec;18(6):561-72. PubMed PMID: 20697266.


27: Piccaluga PP, Agostinelli C, Gazzola A, Mannu C, Bacci F, Sabattini E, Pileri
SA. Prognostic markers in peripheral T-cell lymphoma. Curr Hematol Malig Rep.
2010 Oct;5(4):222-8. Review. Erratum in: Curr Hematol Malig Rep. 2010
Oct;5(4):239. PubMed PMID: 20690003; PubMed Central PMCID: PMC2948168.


28: Tripodo C, Gri G, Piccaluga PP, Frossi B, Guarnotta C, Piconese S, Franco G,
Vetri V, Pucillo CE, Florena AM, Colombo MP, Pileri SA. Mast cells and Th17 cells
contribute to the lymphoma-associated pro-inflammatory microenvironment of
angioimmunoblastic T-cell lymphoma. Am J Pathol. 2010 Aug;177(2):792-802. Epub
2010 Jul 1. PubMed PMID: 20595635; PubMed Central PMCID: PMC2913370.


29: Pantaleo MA, Mishani E, Nanni C, Landuzzi L, Boschi S, Nicoletti G, Dissoki
S, Paterini P, Piccaluga PP, Lodi F, Lollini PL, Fanti S, Biasco G. Evaluation of
modified PEG-anilinoquinazoline derivatives as potential agents for EGFR imaging
in cancer by small animal PET. Mol Imaging Biol. 2010 Dec;12(6):616-25. PubMed
PMID: 20379787; PubMed Central PMCID: PMC2978890.


30: Piva R, Agnelli L, Pellegrino E, Todoerti K, Grosso V, Tamagno I, Fornari A,
Martinoglio B, Medico E, Zamò A, Facchetti F, Ponzoni M, Geissinger E, Rosenwald
A, Müller-Hermelink HK, De Wolf-Peeters C, Piccaluga PP, Pileri S, Neri A,
Inghirami G. Gene expression profiling uncovers molecular classifiers for the
recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms.
J Clin Oncol. 2010 Mar 20;28(9):1583-90. Epub 2010 Feb 16. PubMed PMID: 20159827.


31: Tumwine LK, Agostinelli C, Campidelli C, Othieno E, Wabinga H, Righi S,
Falini B, Piccaluga PP, Byarugaba W, Pileri SA. Immunohistochemical and other
prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda. BMC
Clin Pathol. 2009 Dec 16;9:11. PubMed PMID: 20003543; PubMed Central PMCID:
PMC2805675.


32: Tripodo C, Iannitto E, Florena AM, Pucillo CE, Piccaluga PP, Franco V, Pileri
SA. Gamma-delta T-cell lymphomas. Nat Rev Clin Oncol. 2009 Dec;6(12):707-17. Epub
2009 Nov 10. Review. PubMed PMID: 19901919.


33: Hartmann S, Gesk S, Scholtysik R, Kreuz M, Bug S, Vater I, Döring C,
Cogliatti S, Parrens M, Merlio JP, Kwiecinska A, Porwit A, Piccaluga PP, Pileri
S, Hoefler G, Küppers R, Siebert R, Hansmann ML. High resolution SNP array
genomic profiling of peripheral T cell lymphomas, not otherwise specified,
identifies a subgroup with chromosomal aberrations affecting the REL locus. Br J
Haematol. 2010 Feb;148(3):402-12. Epub 2009 Oct 22. PubMed PMID: 19863542.


34: Giebel S, Stella-Holowiecka B, Krawczyk-Kulis M, Gökbuget N, Hoelzer D,
Doubek M, Mayer J, Piatkowska-Jakubas B, Skotnicki AB, Dombret H, Ribera JM,
Piccaluga PP, Czerw T, Kyrcz-Krzemien S, Holowiecki J; Study Group for Adult ALL
of the European Leukemia Net. Status of minimal residual disease determines
outcome of autologous hematopoietic SCT in adult ALL. Bone Marrow Transplant.
2010 Jun;45(6):1095-101. Epub 2009 Oct 26. PubMed PMID: 19855438.


35: Iacobucci I, Lonetti A, Messa F, Ferrari A, Cilloni D, Soverini S, Paoloni F,
Arruga F, Ottaviani E, Chiaretti S, Messina M, Vignetti M, Papayannidis C, Vitale
A, Pane F, Piccaluga PP, Paolini S, Berton G, Baruzzi A, Saglio G, Baccarani M,
Foà R, Martinelli G. Different isoforms of the B-cell mutator activation-induced
cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute
lymphoblastic leukemia patients. Leukemia. 2010 Jan;24(1):66-73. Epub 2009 Sep
17. PubMed PMID: 19759560.


36: Iacobucci I, Storlazzi CT, Cilloni D, Lonetti A, Ottaviani E, Soverini S,
Astolfi A, Chiaretti S, Vitale A, Messa F, Impera L, Baldazzi C, D'Addabbo P,
Papayannidis C, Lonoce A, Colarossi S, Vignetti M, Piccaluga PP, Paolini S, Russo
D, Pane F, Saglio G, Baccarani M, Foà R, Martinelli G. Identification and
molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1
gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia
patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute
Leukemia Working Party (GIMEMA AL WP). Blood. 2009 Sep 3;114(10):2159-67. Epub
2009 Jul 9. Erratum in: Blood. 2010 Sep 23;116(12):2196. PubMed PMID: 19589926.


37: Gazzola A, Bertuzzi C, Agostinelli C, Righi S, Pileri SA, Piccaluga PP.
Physiological PTEN expression in peripheral T-cell lymphoma not otherwise
specified. Haematologica. 2009 Jul;94(7):1036-7. Epub 2009 Jun 8. PubMed PMID:
19508975; PubMed Central PMCID: PMC2704320.


38: Martinelli G, Iacobucci I, Soverini S, Piccaluga PP, Cilloni D, Pane F. New
mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemia.
Expert Rev Hematol. 2009 Jun;2(3):297-303. Review. PubMed PMID: 21082971.


39: Visani G, Piccaluga P, Malagola M, Isidori A. Efficacy of dasatinib in
conjunction with alpha-interferon for the treatment of imatinib-resistant and
dasatinib-resistant Ph+ acute lymphoblastic leukemia. Leukemia. 2009
Sep;23(9):1687-8. Epub 2009 May 7. PubMed PMID: 19421228.


40: Piccaluga PP, Sabattini E, Bacci F, Agostinelli C, Righi S, Salmi F, Testoni
N, Paolini S, Castagnetti F, Martinelli G, Falini B, Pileri SA. Cytoplasmic
mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia.
Leukemia. 2009 Jul;23(7):1370-1. Epub 2009 May 7. PubMed PMID: 19421226.


41: Iacobucci I, Lonetti A, Cilloni D, Messa F, Ferrari A, Zuntini R, Ferrari S,
Ottaviani E, Arruga F, Paolini S, Papayannidis C, Piccaluga PP, Soverini S,
Saglio G, Pane F, Baruzzi A, Vignetti M, Berton G, Vitale A, Chiaretti S, Müschen
M, Foà R, Baccarani M, Martinelli G. Identification of different Ikaros cDNA
transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a
high-throughput capillary electrophoresis sizing method. Haematologica. 2008
Dec;93(12):1814-21. Epub 2008 Oct 6. Erratum in: Haematologica. 2010
Jun;95(6):1033. PubMed PMID: 18838475.


42: Agostinelli C, Piccaluga PP, Went P, Rossi M, Gazzola A, Righi S, Sista T,
Campidelli C, Zinzani PL, Falini B, Pileri SA. Peripheral T cell lymphoma, not
otherwise specified: the stuff of genes, dreams and therapies. J Clin Pathol.
2008 Nov;61(11):1160-7. Epub 2008 Aug 28. Review. PubMed PMID: 18755717; PubMed
Central PMCID: PMC2582342.


43: Iacobucci I, Lonetti A, Messa F, Cilloni D, Arruga F, Ottaviani E, Paolini S,
Papayannidis C, Piccaluga PP, Giannoulia P, Soverini S, Amabile M, Poerio A,
Saglio G, Pane F, Berton G, Baruzzi A, Vitale A, Chiaretti S, Perini G, Foà R,
Baccarani M, Martinelli G. Expression of spliced oncogenic Ikaros isoforms in
Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine
kinase inhibitors: implications for a new mechanism of resistance. Blood. 2008
Nov 1;112(9):3847-55. Epub 2008 Jul 23. Erratum in: Blood. 2010 Sep
23;116(12):2196. PubMed PMID: 18650450.


44: Malagola M, Peli A, Damiani D, Candoni A, Tiribelli M, Martinelli G,
Piccaluga PP, Paolini S, De Rosa F, Lauria F, Bocchia M, Gobbi M, Pierri I,
Zaccaria A, Zuffa E, Mazza P, Priccolo G, Gugliotta L, Bonini A, Visani G, Skert
C, Bergonzi C, Roccaro AM, Filì C, Fanin R, Baccarani M, Russo D. Incidence of
bacterial and fungal infections in newly diagnosed acute myeloid leukaemia
patients younger than 65 yr treated with induction regimens including
fludarabine: retrospective analysis of 224 cases. Eur J Haematol. 2008
Nov;81(5):354-63. Epub 2008 Aug 19. PubMed PMID: 18637030.


45: Candoni A, Martinelli G, Toffoletti E, Chiarvesio A, Tiribelli M, Malagola M,
Piccaluga PP, Michelutti A, Simeone E, Damiani D, Russo D, Fanin R.
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin
(FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65
years. Leuk Res. 2008 Dec;32(12):1800-8. Epub 2008 Jul 14. PubMed PMID: 18621416.


46: Visani G, Ferrara F, Alesiani F, Ronconi S, Catarini M, D'adamo F, Guiducci
B, Bernardi D, Barulli S, Piccaluga P, Rocchi M, Isidori A. R-COMP 21 for frail
elderly patients with aggressive B-cell non-Hodgkin lymphoma: a pilot study. Leuk
Lymphoma. 2008 Jun;49(6):1081-6. PubMed PMID: 18569635.


47: Piccaluga PP, Califano A, Klein U, Agostinelli C, Bellosillo B, Gimeno E,
Serrano S, Solè F, Zang Y, Falini B, Zinzani PL, Pileri SA. Gene expression
analysis provides a potential rationale for revising the histological grading of
follicular lymphomas. Haematologica. 2008 Jul;93(7):1033-8. Epub 2008 May 19.
PubMed PMID: 18492688.


48: Zinzani PL, Tani M, Pulsoni A, Gobbi M, Perotti A, De Luca S, Fabbri A,
Zaccaria A, Voso MT, Fattori P, Guardigni L, Ronconi S, Cabras MG, Rigacci L, De
Renzo A, Marchi E, Stefoni V, Fina M, Pellegrini C, Musuraca G, Derenzini E,
Pileri S, Fanti S, Piccaluga PP, Baccarani M. Fludarabine and mitoxantrone
followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with
follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).
Lancet Oncol. 2008 Apr;9(4):352-8. Epub 2008 Mar 14. PubMed PMID: 18342572.


49: Piccaluga PP, Martinelli G, Isidori A, Malagola M, Rondoni M, Paolini S,
Amabile M, Iacobucci I, Baccarani M, Visani G. Long-term molecular complete
remission with IFN-alpha in Ph+ adult acute lymphoid leukemia patients. Leukemia.
2008 Aug;22(8):1617-8. Epub 2008 Feb 14. PubMed PMID: 18273047.


50: Piccaluga PP, Malagola M, Rondoni M, Arpinati M, Paolini S, Candoni A, Fanin
R, Messa E, Pirrotta MT, Lauria F, Visani G, Alberti D, Rancati F, Vinaccia V,
Russo D, Saglio G, Baccarani M, Martinelli G. Imatinib mesylate in the treatment
of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia.
Results of an Italian Multicentric Phase II Study. Haematologica. 2007
Dec;92(12):1721-2. PubMed PMID: 18056005.


51: Piccaluga PP, Agostinelli C, Califano A, Carbone A, Fantoni L, Ferrari S,
Gazzola A, Gloghini A, Righi S, Rossi M, Tagliafico E, Zinzani PL, Zupo S,
Baccarani M, Pileri SA. Gene expression analysis of angioimmunoblastic lymphoma
indicates derivation from T follicular helper cells and vascular endothelial
growth factor deregulation. Cancer Res. 2007 Nov 15;67(22):10703-10. PubMed PMID:
18006812.


52: Piccaluga PP, Rondoni M, Paolini S, Rosti G, Martinelli G, Baccarani M.
Imatinib mesylate in the treatment of hematologic malignancies. Expert Opin Biol
Ther. 2007 Oct;7(10):1597-611. Review. PubMed PMID: 17916051.


53: Piccaluga PP, Paolini S, Martinelli G. Tyrosine kinase inhibitors for the
treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
Cancer. 2007 Sep 15;110(6):1178-86. Review. PubMed PMID: 17701954.


54: Piccaluga PP, Finelli C, Vigna E, Agostinelli C, Bacci F, Paolini S,
Papayannidis C, Laterza C, Martinelli G, Pileri SA, Baccarani M. Paraplegia due
to a paravertebral extramedullary haemopoiesis in a patient with polycythaemia
vera. J Clin Pathol. 2007 May;60(5):581-2. Erratum in: J Clin Pathol. 2007
Jul;60(7):848. Padiai, Stefania [corrected to Paolini, Stefania]. PubMed PMID:
17513521; PubMed Central PMCID: PMC1994544.


55: Piccaluga PP, Agostinelli C, Righi S, Zinzani PL, Pileri SA. Expression of
CD52 in peripheral T-cell lymphoma. Haematologica. 2007 Apr;92(4):566-7. PubMed
PMID: 17488672.


56: De Falco G, Leucci E, Lenze D, Piccaluga PP, Claudio PP, Onnis A, Cerino G,
Nyagol J, Mwanda W, Bellan C, Hummel M, Pileri S, Tosi P, Stein H, Giordano A,
Leoncini L. Gene-expression analysis identifies novel RBL2/p130 target genes in
endemic Burkitt lymphoma cell lines and primary tumors. Blood. 2007 Aug
15;110(4):1301-7. Epub 2007 May 7. PubMed PMID: 17485552.


57: Piccaluga PP, Ascani S, Agostinelli C, Paolini S, Laterza C, Papayannidis C,
Martinelli G, Visani G, Baccarani M, Pileri SA. Myeloid sarcoma of liver: an
unusual cause of jaundice. Report of three cases and review of literature.
Histopathology. 2007 May;50(6):802-5. Epub 2007 Mar 13. Review. PubMed PMID:
17355272.


58: Soverini S, Colarossi S, Gnani A, Castagnetti F, Rosti G, Bosi C, Paolini S,
Rondoni M, Piccaluga PP, Palandri F, Giannoulia P, Marzocchi G, Luatti S, Testoni
N, Iacobucci I, Cilloni D, Saglio G, Baccarani M, Martinelli G. Resistance to
dasatinib in Philadelphia-positive leukemia patients and the presence or the
selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain.
Haematologica. 2007 Mar;92(3):401-4. PubMed PMID: 17339191.


59: Piccaluga PP, Agostinelli C, Califano A, Rossi M, Basso K, Zupo S, Went P,
Klein U, Zinzani PL, Baccarani M, Dalla Favera R, Pileri SA. Gene expression
analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles
and new potential therapeutic targets. J Clin Invest. 2007 Mar;117(3):823-34.
Epub 2007 Feb 15. PubMed PMID: 17304354; PubMed Central PMCID: PMC1794115.


60: Malagola M, Damiani D, Martinelli G, Michelutti A, Cesana B, Vivo AD,
Piccaluga PP, Ottaviani E, Candoni A, Geromin A, Tiribelli M, Fanin R, Testoni N,
Lauria F, Bocchia M, Gobbi M, Pierri I, Zaccaria A, Zuffa E, Mazza P, Priccolo G,
Gugliotta L, Bonini A, Visani G, Skert C, Bergonzi C, Roccaro AM, Filí C,
Baccarani M, Russo D. Case-control study of multidrug resistance phenotype and
response to induction treatment including or not fludarabine in newly diagnosed
acute myeloid leukaemia patients. Br J Haematol. 2007 Jan;136(1):87-95. PubMed
PMID: 17222198.


61: Pileri SA, Ascani S, Cox MC, Campidelli C, Bacci F, Piccioli M, Piccaluga PP,
Agostinelli C, Asioli S, Novero D, Bisceglia M, Ponzoni M, Gentile A, Rinaldi P,
Franco V, Vincelli D, Pileri A Jr, Gasbarra R, Falini B, Zinzani PL, Baccarani M.
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92
adult patients. Leukemia. 2007 Feb;21(2):340-50. Epub 2006 Dec 14. PubMed PMID:
17170724.


62: Visani G, Mele A, Guiducci B, D'Adamo F, Leopardi G, Barulli S, Malerba L,
Lucesole M, Sparaventi G, Piccaluga PP, Guernaccini E, Agostinelli F, Isidori A.
An observational study of once weekly intravenous ganciclovir as CMV prophylaxis
in heavily pre-treated chronic lymphocytic leukemia patients receiving
subcutaneous alemtuzumab. Leuk Lymphoma. 2006 Dec;47(12):2542-6. PubMed PMID:
17169798.


63: Soverini S, Martinelli G, Colarossi S, Gnani A, Castagnetti F, Rosti G, Bosi
C, Paolini S, Rondoni M, Piccaluga PP, Palandri F, Giannoulia P, Marzocchi G,
Luatti S, Testoni N, Iacobucci I, Cilloni D, Saglio G, Baccarani M. Presence or
the emergence of a F317L BCR-ABL mutation may be associated with resistance to
dasatinib in Philadelphia chromosome-positive leukemia. J Clin Oncol. 2006 Nov
20;24(33):e51-2. PubMed PMID: 17114651.


64: Piccaluga PP, Martinelli G, Rondoni M, Visani G, Baccarani M. Advances and
potential treatment for Philadelphia chromosome-positive adult acute lymphoid
leukaemia. Expert Opin Biol Ther. 2006 Oct;6(10):1011-22. Review. PubMed PMID:
16989583.


65: Tagliafico E, Tenedini E, Manfredini R, Grande A, Ferrari F, Roncaglia E,
Bicciato S, Zini R, Salati S, Bianchi E, Gemelli C, Montanari M, Vignudelli T,
Zanocco-Marani T, Parenti S, Paolucci P, Martinelli G, Piccaluga PP, Baccarani M,
Specchia G, Torelli U, Ferrari S. Identification of a molecular signature
predictive of sensitivity to differentiation induction in acute myeloid leukemia.
Leukemia. 2006 Oct;20(10):1751-8. Epub 2006 Aug 17. PubMed PMID: 16932344.


66: Piccaluga PP, Vigna E, Placci A, Agostinelli C, Laterza C, Papayannidis C,
Leone O, Martinelli G, Zinzani PL, Baccarani M, Pileri SA. Primary cardiac
non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion. Br
J Haematol. 2006 Aug;134(4):356. PubMed PMID: 16882130.


67: Visani G, Olivieri A, Malagola M, Brunori M, Piccaluga PP, Capelli D,
Pomponio G, Martinelli G, Isidori A, Sparaventi G, Leoni P. Consolidation therapy
for adult acute myeloid leukemia: a systematic analysis according to evidence
based medicine. Leuk Lymphoma. 2006 Jun;47(6):1091-102. PubMed PMID: 16840201.


68: Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E,
Bacci F, Falini B, Motta T, Paulli M, Artusi T, Piccioli M, Zinzani PL, Pileri
SA. Marker expression in peripheral T-cell lymphoma: a proposed
clinical-pathologic prognostic score. J Clin Oncol. 2006 Jun 1;24(16):2472-9.
Epub 2006 Apr 24. PubMed PMID: 16636342.


69: Piccaluga PP, Martinelli G, Baccarani M. Advances in the treatment for
haematological malignancies. Expert Opin Pharmacother. 2006 Apr;7(6):721-32.
Review. PubMed PMID: 16556088.


70: Piccaluga PP, Malagola M, Rondoni M, Ottaviani E, Testoni N, Laterza C,
Visani G, Pileri SA, Martinelli G, Baccarani M. Poor outcome of adult acute
lymphoblastic leukemia patients carrying the (1;19)(q23;p13) translocation. Leuk
Lymphoma. 2006 Mar;47(3):469-72. PubMed PMID: 16396770.


71: Nyåkern M, Tazzari PL, Finelli C, Bosi C, Follo MY, Grafone T, Piccaluga PP,
Martinelli G, Cocco L, Martelli AM. Frequent elevation of Akt kinase
phosphorylation in blood marrow and peripheral blood mononuclear cells from
high-risk myelodysplastic syndrome patients. Leukemia. 2006 Feb;20(2):230-8.
PubMed PMID: 16341040.


72: Russo D, Malagola M, de Vivo A, Fiacchini M, Martinelli G, Piccaluga PP,
Damiani D, Candoni A, Michielutti A, Castelli M, Testoni N, Ottaviani E, Rondoni
M, Pricolo G, Mazza P, Zuffa E, Zaccaria A, Raspadori D, Bocchia M, Lauria F,
Bonini A, Avanzini P, Gugliotta L, Visani G, Fanin R, Baccarani M. Multicentre
phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus
idarubicin, Ara-C and etoposide for induction treatment of younger, newly
diagnosed acute myeloid leukaemia patients. Br J Haematol. 2005 Oct;131(2):172-9.
Erratum in: Br J Haematol. 2006 Mar;132(6):804. PubMed PMID: 16197446.


73: van der Holt B, Löwenberg B, Burnett AK, Knauf WU, Shepherd J, Piccaluga PP,
Ossenkoppele GJ, Verhoef GE, Ferrant A, Crump M, Selleslag D, Theobald M, Fey MF,
Vellenga E, Dugan M, Sonneveld P. The value of the MDR1 reversal agent PSC-833 in
addition to daunorubicin and cytarabine in the treatment of elderly patients with
previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at
diagnosis. Blood. 2005 Oct 15;106(8):2646-54. Epub 2005 Jun 30. PubMed PMID:
15994288.


74: Piccaluga PP, Agostinelli C, Zinzani PL, Baccarani M, Dalla Favera R, Pileri
SA. Expression of platelet-derived growth factor receptor alpha in peripheral
T-cell lymphoma not otherwise specified. Lancet Oncol. 2005 Jun;6(6):440. PubMed
PMID: 15925824.


75: Mele A, Leopardi G, Sparaventi G, Nicolini G, D'Adamo F, Guiducci B, Barulli
S, Malerba L, Stramigioli S, Talevi N, Politi P, Isidori A, Malagola M, Piccaluga
P, Visani G. Mini-ICE effectively mobilises peripheral blood stem cells after
fludarabine-based regimens in acute myeloid leukaemia. Eur J Haematol. 2005
Apr;74(4):277-81. PubMed PMID: 15777338.


76: Zinzani PL, Dirnhofer S, Sabattini E, Alinari L, Piccaluga PP, Stefoni V,
Tani M, Musuraca G, Marchi E, Falini B, Baccarani M, Pileri SA. Identification of
outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical
profiling of homogeneously treated de novo tumors with nodal presentation on
tissue micro-arrays. Haematologica. 2005 Mar;90(3):341-7. PubMed PMID: 15749666.


77: Pileri SA, Piccaluga PP, Sabattini E, Zinzani PL. The development of more
than one histologic type of lymphoma in the same patient is frequent and confers
a worse prognosis. Haematologica. 2005 Mar;90(3):293. PubMed PMID: 15749657.


78: Malagola M, Martinelli G, Rondoni M, Paolini S, Gaitani S, Arpinati M,
Piccaluga PP, Amabile M, Basi C, Ottaviani E, Candoni A, Gottardi E, Cilloni D,
Bocchia M, Saglio G, Lauria F, Fanin R, Visani G, Marrè MC, Maderna M, Rancati F,
Vinaccia V, Russo D, Baccarani M. Imatinib mesylate in the treatment of
c-kit-positive acute myeloid leukemia: is this the real target? Blood. 2005 Jan
15;105(2):904; author reply 905. PubMed PMID: 15632213.


79: Visani G, Guiducci B, D'Adamo F, Mele A, Nicolini G, Leopardi G, Sparaventi
G, Barulli S, Malerba L, Isidori A, Malagola M, Piccaluga PP. Cyclophosphamide,
pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab
is effective and well tolerated in poor performance status elderly patients with
non-Hodgkin's lymphoma. Leuk Lymphoma. 2005 Mar;46(3):477-9. PubMed PMID:
15621843.


80: Piccaluga PP, Martinelli G, Malagola M, Rondoni M, Bonifazi F, Bandini G,
Visani G, Baccarani M. Alemtuzumab in the treatment of relapsed acute lymphoid
leukaemia. Leukemia. 2005 Jan;19(1):135; author reply 136. PubMed PMID: 15510200.


81: Piccaluga PP, Malagola M, Amabile M, Rondoni M, Paolini S, Pane F, Russo D,
Visani G, Baccarani M, Martinelli G. The achievement of molecular complete
remission during treatment with imatinib mesylate correlates with relapse-free
survival in bcr/abl-positive acute lymphoid leukemia patients. Haematologica.
2004 Oct;89(10):1269-71. PubMed PMID: 15477218.


82: Visani G, Malagola M, Piccaluga PP, Isidori A. Low dose Ara-C for
myelodysplastic syndromes: is it still a current therapy? Leuk Lymphoma. 2004
Aug;45(8):1531-8. Review. PubMed PMID: 15370203.


83: Visani G, Isidori A, Grafone T, Tosi P, Santini V, Malagola M, Martinelli G,
Piccaluga PP, Gaziev D, Ottaviani E, Sparaventi G, Tura S. No preferential
sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro:
is intensity of therapy or high dose Ara-C crucial for response? Leuk Lymphoma.
2004 Jul;45(7):1361-4. PubMed PMID: 15359633.


84: Malagola M, Martinelli G, Rondoni M, Ottaviani E, Piccaluga PP, Ricci P,
Visani G, Baccarani M. Soft tissue and skeletal involvement in FIP1L1-PDGFR-alpha
positive chronic eosinophilic leukemia: imatinib mesylate may induce complete
molecular and imaging remission. Haematologica. 2004 Aug;89(8):ECR25. PubMed
PMID: 15339694.


85: Piccaluga PP, Martinelli G, Rondoni M, Malagola M, Gaitani S, Visani G,
Baccarani M. First experience with gemtuzumab ozogamicin plus cytarabine as
continuous infusion for elderly acute myeloid leukaemia patients. Leuk Res. 2004
Sep;28(9):987-90. PubMed PMID: 15234577.


86: Piccaluga PP, Martinelli G, Rondoni M, Malagola M, Gaitani S, Isidori A,
Bonini A, Gugliotta L, Luppi M, Morselli M, Sparaventi G, Visani G, Baccarani M.
Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and
myeloid sarcomas. Leuk Lymphoma. 2004 Sep;45(9):1791-5. PubMed PMID: 15223637.


87: Mele A, Sparaventi G, Guiducci B, Nicolini G, d'Adamo F, Leopardi G, Delfini
C, Piccaluga P, Visani G. Gemtuzumab ozogamicin plus cytarabine determines
complete remission in acute myeloid leukemia refractory to a double conventional
treatment: a case report. Haematologica. 2004 Jun 1;89(6 Suppl):ECR18. PubMed
PMID: 15194554.


88: Piccaluga PP, Martinelli G, Malagola M, Rondoni M, Bianchini M, Vigna E, Bosi
C, Gaitani S, Visani G, Baccarani M. Anti-leukemic and anti-GVHD effects of
campath-1H in acute lymphoblastic leukemia relapsed after stem-cell
transplantation. Leuk Lymphoma. 2004 Apr;45(4):731-3. PubMed PMID: 15160947.


89: Piccaluga PP, Ricci P, Martinelli G, Malagola M, Rondoni M, Visani G. Prompt
resolution of nasal aspergillosis with intranasal instillation of liposomal
amphotericin-B (amBisome) and granulocyte transfusions. Leuk Lymphoma. 2004
Mar;45(3):637-8. PubMed PMID: 15160933.


90: Piccaluga PP, Luatti S, Ascani S, Bianchini M, Malagola M, Rondoni M, Gaitani
S, Testoni N, Pileri SA, Baccarani M, Martinelli G, Visani G. Identification of a
novel t(1;9)(q11;q34) in acute myelocytic leukemia. Cancer Genet Cytogenet. 2004
May;151(1):85-6. PubMed PMID: 15120916.


91: Piccaluga PP, Malagola M, Rondoni M, Amabile M, Paolini S, Soverini S,
Gaitani S, Visani G, Baccarani M, Martinelli G. Dose increase of imatinib
mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid
leukaemia. Eur J Haematol. 2004 Apr;72(4):302-3. PubMed PMID: 15089772.


92: Ascani S, Sabattini E, Agostinelli C, Piccaluga PP, Zinzani PL, Pileri SA.
Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic
syndrome. Haematologica. 2004 Apr;89(4):EIM07. PubMed PMID: 15075110.


93: Martinelli G, Rondoni M, Buonamici S, Ottaviani E, Piccaluga PP, Malagola M,
Baccarani M. Molecular monitoring to identify a threshold of CBFbeta/MYH11
transcript below which continuous complete remission of acute myeloid leukemia
inv16 is likely. Haematologica. 2004 Apr;89(4):495-7. PubMed PMID: 15075086.


94: Piccaluga PP, Poletti G, Martinelli G, Gherlinzoni F. Babesia infection in
Italy. Lancet Infect Dis. 2004 Apr;4(4):212. PubMed PMID: 15050938.


95: Ascani S, Went P, Liberati AM, Piccaluga PP, Zinzani PL, Pileri SA. Difficult
diagnostic and therapeutic cases: CASE 1. true thymic hyperplasia in a patient
treated for T-cell lymphoma. J Clin Oncol. 2004 Mar 1;22(5):953-4. PubMed PMID:
14990652.


96: Piccaluga PP, Martinelli G, Rondoni M, Malagola M, Ronconi S, Visani G,
Baccarani M. Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia
in elderly. Haematologica. 2003 Dec;88(12):ECR37. PubMed PMID: 14688010.


97: Martinelli G, Ottaviani E, Buonamici S, Isidori A, Borsaru G, Visani G,
Piccaluga PP, Malagola M, Testoni N, Rondoni M, Nucifora G, Tura S, Baccarani M.
Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts.
Haematologica. 2003 Nov;88(11):1221-8. PubMed PMID: 14607750.


98: Piccaluga PP, Bianchini M, Martinelli G. Novel FLT3 point mutation in acute
myeloid leukaemia. Lancet Oncol. 2003 Oct;4(10):604. PubMed PMID: 14554237.


99: Bianchini M, Ottaviani E, Grafone T, Giannini B, Soverini S, Terragna C,
Amabile M, Piccaluga PP, Malagola M, Rondoni M, Bosi C, Baccarani M, Martinelli
G. Rapid detection of Flt3 mutations in acute myeloid leukemia patients by
denaturing HPLC. Clin Chem. 2003 Oct;49(10):1642-50. PubMed PMID: 14500589.


100: Herwaldt BL, Cacciò S, Gherlinzoni F, Aspöck H, Slemenda SB, Piccaluga P,
Martinelli G, Edelhofer R, Hollenstein U, Poletti G, Pampiglione S, Löschenberger
K, Tura S, Pieniazek NJ. Molecular characterization of a non-Babesia divergens
organism causing zoonotic babesiosis in Europe. Emerg Infect Dis. 2003
Aug;9(8):942-8. PubMed PMID: 12967491.


101: Piccaluga PP, Martinelli G, Malagola M, Rondoni M, Bianchini M, Visani G,
Baccarani M. Complete remission in acute myeloid leukemia with granulocyte-colony
stimulating factor without chemotherapy. Report of cytogenetic remission of a
t(9;11)(p22q23) positive AML patient and review of literature. Haematologica.
2003 Aug;88(8):ECR28. Review. PubMed PMID: 12935987.


102: Visani G, Mele A, Malagola M, Isidori A, Finelli C, Piccaluga PP. Sequential
combination of thalidomide and erythropoietin determines transfusion independence
and disease control in idiopathic myelofibrosis previously insensitive to both
drugs used as single agents. Leukemia. 2003 Aug;17(8):1669-70. PubMed PMID:
12886259.


103: Ascani S, Piccaluga PP, Pileri SA. Granulocytic sarcoma of main biliary
ducts. Br J Haematol. 2003 May;121(4):534. PubMed PMID: 12752094.


104: Piccaluga PP, Visani G, Isidori A, Malagola M, Ascani S, Pileri SA.
Microdose alpha-interferon shows clinical and antiangiogenic effect in
extramedullary myeloid tumor: a case report. Leukemia. 2003 May;17(5):986-7.
PubMed PMID: 12750719.


105: Visani G, Piccaluga PP, Martinelli G, Rossi M, Malagola M, Baccarani M.
Sustained molecular remission in advanced acute promyelocytic leukemia with
combined pulsed retinoic acid and arsenic trioxide. Clinical evidence of
synergistic effect and real-time quantification of minimal residual disease.
Haematologica. 2003 Apr;88(4):ELT15. PubMed PMID: 12681992.


106: Martinelli G, Buonamici S, Visani G, Malagola M, Piccaluga PP, Isidori A,
Bosi C, Bonifazi F, Soverini S, Terragna C, Amabile M, Giannini B, Baccarani M.
Molecular monitoring of acute myeloid leukemia associated with inv(16): threshold
of CBFbeta/MYH11 transcript copy number above which relapse occurs and below
which continuous Complete Remission is likely. Leukemia. 2003 Mar;17(3):650-1;
author reply 651-2. PubMed PMID: 12646962.


107: Barosi G, Elliott M, Canepa L, Ballerini F, Piccaluga PP, Visani G,
Marchetti M, Pozzato G, Zorat F, Tefferi A. Thalidomide in myelofibrosis with
myeloid metaplasia: a pooled-analysis of individual patient data from five
studies. Leuk Lymphoma. 2002 Dec;43(12):2301-7. Erratum in: Leuk Lymphoma. 2009
Dec;50(12):2102. Giovanni, Barosi [corrected to Barosi, Giovanni]; Michelle,
Elliott [corrected to Elliott, Michelle]; Letizia, Canepa [corrected to Canepa,
Letizia]; Filippo, Ballerini [corrected to Ballerini, Filippo]; Pier Paolo,
Piccaluga [corrected to Piccaluga, Pier Paolo]; Giuseppe, Visani [corrected to
Visani, Giuseppe]; Monia, Marchetti [corrected to Marchetti, Monia]; Gabriele,
Pozzato [corrected to Pozzato, Gabriele]; Francesca, Zorat [corrected to Zorat,
Francesca]; Ayalew, Tefferi [corrected to Tefferi, Ayalew]. PubMed PMID:
12613516.


108: Pagano L, Mele L, Fianchi L, Rutella S, Piscitelli R, Leone G, Pulsoni A, De
Fabritiis P, Foà R, Mandelli F, Visani G, Piccaluga P, Di Bona E, Cerri R, Risso
M, Tosti ME, Venditti A; GIMEMA Study Group on Secondary Leukemias.
Immunophenotypic analysis in 119 patients with acute myeloid leukemia following a
previous malignancy: a comparison with the immunophenotype of 231 de novo AML.
Haematologica. 2003 Feb;88(2):225-7. PubMed PMID: 12604416.


109: Martinelli G, Piccaluga PP, Lo Coco F. FLT3 inhibition as tailored therapy
for acute myeloid leukemia. Haematologica. 2003 Jan;88(1):4-8. PubMed PMID:
12551818.


110: Pileri SA, Gaidano G, Zinzani PL, Falini B, Gaulard P, Zucca E, Pieri F,
Berra E, Sabattini E, Ascani S, Piccioli M, Johnson PW, Giardini R, Pescarmona E,
Novero D, Piccaluga PP, Marafioti T, Alonso MA, Cavalli F. Primary mediastinal
B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of
the transcription factors OCT-2, BOB.1, and PU.1 in the absence of
immunoglobulins. Am J Pathol. 2003 Jan;162(1):243-53. PubMed PMID: 12507907;
PubMed Central PMCID: PMC1851125.


111: Pileri SA, Ascani S, Zinzani PL, Gaidano G, Piccioli M, Rossi M, Piccaluga
PP, Marafioti T, Pileri A Jr, Pacini R, Falini B, Sabattini E. Diffuse large
B-cell lymphoma (DLBCL), anaplastic variant. report on a problematic case
primarily arising in the stomach. Haematologica. 2002 Dec;87(12):ECR40. PubMed
PMID: 12495911.


112: Visani G, Isidori A, Malagola M, Alberti D, Capdeville R, Martinelli G,
Piccaluga PP, Amabile M, Guiducci B, Tura S, Baccarani M. Efficacy of imatinib
mesylate (STI571) in conjunction with alpha-interferon: long-term quantitative
molecular remission in relapsed P-190(BCR-ABL)-positive acute lymphoblastic
leukemia. Leukemia. 2002 Oct;16(10):2159-60. PubMed PMID: 12357372.


113: Russo D, Piccaluga PP, Michieli M, Michelutti T, Visani G, Gugliotta L,
Bonini A, Pierri I, Gobbi M, Tiribelli M, Fanin R, Piccolrovazzi S, Baccarani M.
Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia. Ann
Hematol. 2002 Aug;81(8):462-6. Epub 2002 Aug 27. PubMed PMID: 12224004.


114: Piccaluga PP, Visani G, Martinelli G, Isidori A, Malagola M, Rondoni M,
Baccarani M, Tura S. Liposomal daunorubicin (DaunoXome) for treatment of relapsed
meningeal acute myeloid leukemia. Leukemia. 2002 Sep;16(9):1880-1. PubMed PMID:
12200714.


115: Piccaluga PP, Visani G, Pileri SA, Ascani S, Grafone T, Isidori A, Malagola
M, Finelli C, Martinelli G, Ricci P, Baccarani M, Tura S. Clinical efficacy and
antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia.
A pilot study. Leukemia. 2002 Sep;16(9):1609-14. PubMed PMID: 12200671.


116: Zinzani PL, Tani M, Stefoni V, Piccaluga PP, Baccarani M, Ascani S, Pileri
S. From chronic lymphocytic leukemia to Hodgkin's disease: a case of
prognostically favorable transformation. Leuk Res. 2002 Aug;26(8):775-6. PubMed
PMID: 12191574.


117: Martinelli G, Ottaviani E, Buonamici S, Isidori A, Malagola M, Piccaluga P,
Baccarani M. Two more inv(16) acute myeloid leukemia cases with infrequent
CBFbeta-MYH11 fusion transcript: clinical and molecular findings. Haematologica.
2002 May;87(5):554-5. PubMed PMID: 12010674.


118: Pagano L, Fianchi L, Mele L, Girmenia C, Offidani M, Ricci P, Mitra ME,
Picardi M, Caramatti C, Piccaluga P, Nosari A, Buelli M, Allione B, Cortelezzi A,
Fabbiano F, Milone G, Invernizzi R, Martino B, Masini L, Todeschini G, Cappucci
MA, Russo D, Corvatta L, Martino P, Del Favero A. Pneumocystis carinii pneumonia
in patients with malignant haematological diseases: 10 years' experience of
infection in GIMEMA centres. Br J Haematol. 2002 May;117(2):379-86. PubMed PMID:
11972521.


119: Pileri SA, Ascani S, Leoncini L, Sabattini E, Zinzani PL, Piccaluga PP,
Pileri A Jr, Giunti M, Falini B, Bolis GB, Stein H. Hodgkin's lymphoma: the
pathologist's viewpoint. J Clin Pathol. 2002 Mar;55(3):162-76. Review. PubMed
PMID: 11896065; PubMed Central PMCID: PMC1769601.


120: Piccaluga PP, Visani G, Finelli C, Grafone T, Baccarani M, Tura S. Efficacy
of thalidomide in the treatment of myelodysplastic syndromes. Haematologica. 2002
Mar;87(3):ELT18. PubMed PMID: 11869964.


121: Buonamici S, Ottaviani E, Testoni N, Montefusco V, Visani G, Bonifazi F,
Amabile M, Terragna C, Ruggeri D, Piccaluga PP, Isidori A, Malagola M, Baccarani
M, Tura S, Martinelli G. Real-time quantitation of minimal residual disease in
inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse
and may identify patients in a curable state. Blood. 2002 Jan 15;99(2):443-9.
PubMed PMID: 11781223.


122: Pileri SA, Zinzani PL, Ascani S, Orcioni GF, Gamberi B, Piccioli M,
Sabattini E, Poggi S, Piccaluga PP, Falini B. Diffuse large B-cell lymphoma with
primary retroperitoneal presentation: clinico-pathologic study of nine cases. Ann
Oncol. 2001 Oct;12(10):1445-53. PubMed PMID: 11762818.


123: Visani G, Buonamici S, Malagola M, Isidori A, Piccaluga PP, Martinelli G,
Ottaviani E, Grafone T, Baccarani M, Tura S. Pulsed ATRA as single therapy
restores long-term remission in PML-RARalpha-positive acute promyelocytic
leukemia patients: real time quantification of minimal residual disease. A pilot
study. Leukemia. 2001 Nov;15(11):1696-700. PubMed PMID: 11681409.


124: Pileri SA, Facchetti F, Ascani S, Sabattini E, Poggi S, Piccioli M, Rondelli
D, Vergoni F, Zinzani PL, Piccaluga PP, Falini B, Isaacson PG. Myeloperoxidase
expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy. Am J
Pathol. 2001 Sep;159(3):915-24. PubMed PMID: 11549584; PubMed Central PMCID:
PMC1850446.


125: Visani G, Lemoli RM, Isidori A, Piccaluga PP, Martinelli G, Malagola M,
Gugliotta L, Bonini A, Bonifazi F, Motta MR, Rizzi S, Castellani S, Tura S.
Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of
autologous stem cell transplantation in acute myeloid leukemia patients. Bone
Marrow Transplant. 2001 Apr;27(8):829-35. PubMed PMID: 11477440.


126: Visani G, Bernasconi P, Boni M, Castoldi GL, Ciolli S, Clavio M, Cox MC,
Cuneo A, Del Poeta G, Dini D, Falzetti D, Fanin R, Gobbi M, Isidori A, Leoni F,
Liso V, Malagola M, Martinelli G, Mecucci C, Piccaluga PP, Petti MC, Rondelli R,
Russo D, Sessarego M, Specchia G, Testoni N, Torelli G, Mandelli F, Tura S. The
prognostic value of cytogenetics is reinforced by the kind of
induction/consolidation therapy in influencing the outcome of acute myeloid
leukemia--analysis of 848 patients. Leukemia. 2001 Jun;15(6):903-9. Review.
PubMed PMID: 11417475.


127: Visani G, Milligan D, Leoni F, Chang J, Kelsey S, Marcus R, Powles R, Schey
S, Covelli A, Isidori A, Litchman M, Piccaluga PP, Mayer H, Malagola M, Pfister
C. Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with
mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia.
Leukemia. 2001 May;15(5):764-71. PubMed PMID: 11368437.


128: Pileri SA, Ascani S, Sabattini E, Fraternali-Orcioni G, Poggi S, Piccioli M,
Piccaluga PP, Gamberi B, Zinzani PL, Leoncini L, Falini B. The pathologist's view
point. Part II --aggressive lymphomas. Haematologica. 2000 Dec;85(12):1308-21.
Review. PubMed PMID: 11114138.


129: Pileri SA, Ascani S, Sabattini E, Fraternali-Orcioni G, Poggi S, Piccioli M,
Piccaluga PP, Gamberi B, Zinzani PL, Leoncini L, Falini B. The pathologist's view
point. Part I--indolent lymphomas. Haematologica. 2000 Dec;85(12):1291-307.
Review. PubMed PMID: 11114137.


130: Zinzani PL, Ascani S, Piccaluga PP, Bendandi M, Pileri S, Tura S. Efficacy
of rituximab in hairy cell leukemia treatment. J Clin Oncol. 2000 Nov
15;18(22):3875-7. PubMed PMID: 11078503.


131: Visani G, Pagano L, Pulsoni A, Tosi P, Piccaluga PP, Pastano R, Grafone T,
Malagola M, Isidori A, Tura S. Chemotherapy of secondary leukemias. Leuk
Lymphoma. 2000 May;37(5-6):543-9. Review. PubMed PMID: 11042514.


132: Visani G, Gugliotta L, Tosi P, Catani L, Vianelli N, Martinelli G, Ottaviani
E, Testoni N, Nocentini F, Pastano R, Piccaluga P, Isidori A, Grafone T, Tura S.
All-trans retinoic acid significantly reduces the incidence of early hemorrhagic
death during induction therapy of acute promyelocytic leukemia. Eur J Haematol.
2000 Mar;64(3):139-44. PubMed PMID: 10997878.


133: Piccaluga PP, Ascani S, Fraternali Orcioni G, Piccioli M, Pileri Jr A,
Falini B, Pileri S. Anaplastic lymphoma kinase expression as a marker of
malignancy. Application to a case of anaplastic large cell lymphoma with huge
granulomatous reaction. Haematologica. 2000 Sep;85(9):978-81. PubMed PMID:
10980638.


134: Zinzani PL, Bendandi M, Stefoni V, Albertini P, Gherlinzoni F, Tani M,
Piccaluga PP, Tura S. Value of gemcitabine treatment in heavily pretreated
Hodgkin's disease patients. Haematologica. 2000 Sep;85(9):926-9. PubMed PMID:
10980630.


135: Visani G, Rosti G, Bandini G, Tosi P, Isidori A, Malagola M, Stanzani M,
Martinelli G, Piccaluga P, Testoni N, Ricci P, Tura S. Second chronic phase
before transplantation is crucial for improving survival of blastic phase chronic
myeloid leukaemia. Br J Haematol. 2000 Jun;109(4):722-8. PubMed PMID: 10929021.


136: Pileri SA, Fraternali-Orcioni G, Ascani S, Piccioli M, Poggi S, Piccaluga
PP, Leoncini L, Falini B. [Aggressive lymphomas: a convenient concept or an
anatomo-pathological reality?]. Pathologica. 2000 Jun;92(3):145-61. Review.
Italian. PubMed PMID: 10902425.


137: Visani G, Martinelli G, Piccaluga P, Tosi P, Amabile M, Pastano R, Cavo M,
Isidori A, Tura S. Alpha-interferon improves survival and remission duration in
P-190BCR-ABL positive adult acute lymphoblastic leukemia. Leukemia. 2000
Jan;14(1):22-7. PubMed PMID: 10637472.


138: Visani G, Lemoli R, Tosi P, Martinelli G, Testoni N, Ricci P, Motta M,
Gherlinzoni F, Leopardi G, Pastano R, Rizzi S, Piccaluga P, Isidori A, Tura S.
Use of peripheral blood stem cells for autologous transplantation in acute
myeloid leukemia patients allows faster engraftment and equivalent disease-free
survival compared with bone marrow cells. Bone Marrow Transplant. 1999
Sep;24(5):467-72. PubMed PMID: 10482929.


139: Visani G, Lemoli RM, Tosi P, Martinelli G, Testoni N, Ricci P, Piccaluga PP,
Pastano R, Leopardi G, Dizdari A, Motta MR, Rizzi S, Tura S.
Fludarabine-containing regimens severely impair peripheral blood stem cells
mobilization and collection in acute myeloid leukaemia patients. Br J Haematol.
1999 Jun;105(3):775-9. PubMed PMID: 10354146.


140: Pileri SA, Roncador G, Ceccarelli C, Piccioli M, Sabattini E, Briskomatis A,
Santini D, Leone O, Piccaluga PP, Leoncini L, Falini B. Immunohistochemistry of
bone-marrow biopsy. Leuk Lymphoma. 1997 Dec;26 Suppl 1:69-75. PubMed PMID:
9570682.


141: Ascani S, Piccioli M, Poggi S, Briskomatis A, Bolis GB, Liberati F,
Frongillo R, Caramatti C, Fraternali-Orcioni G, Gamberi B, Zinzani PL, Lazzi S,
Leoncini L, O'Leary J, Piccaluga PP, Pileri SA. Pyothorax-associated lymphoma:
description of the first two cases detected in Italy. Ann Oncol. 1997
Nov;8(11):1133-8. PubMed PMID: 9426333.


142: Pileri SA, Roncador G, Ceccarelli C, Piccioli M, Briskomatis A, Sabattini E,
Ascani S, Santini D, Piccaluga PP, Leone O, Damiani S, Ercolessi C, Sandri F,
Pieri F, Leoncini L, Falini B. Antigen retrieval techniques in
immunohistochemistry: comparison of different methods. J Pathol. 1997
Sep;183(1):116-23. PubMed PMID: 9370957.


143: Ascani S, Zinzani PL, Gherlinzoni F, Sabattini E, Briskomatis A, de Vivo A,
Piccioli M, Fraternali Orcioni G, Pieri F, Goldoni A, Piccaluga PP, Zallocco D,
Burnelli R, Leoncini L, Falini B, Tura S, Pileri SA. Peripheral T-cell lymphomas.
Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L.
Classification. Ann Oncol. 1997 Jun;8(6):583-92. PubMed PMID: 9261528.


144: Pileri SA, Pulford K, Mori S, Mason DY, Sabattini E, Roncador G, Piccioli M,
Ceccarelli C, Piccaluga PP, Santini D, Leone O, Stein H, Falini B. Frequent
expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell
lymphoma, lympho-histiocytic type. Am J Pathol. 1997 Apr;150(4):1207-11. PubMed
PMID: 9094977; PubMed Central PMCID: PMC1858171.


145: Pileri SA, Piccaluga A, Poggi S, Sabattini E, Piccaluga PP, De Vivo A,
Falini B, Stein H. Anaplastic large cell lymphoma: update of findings. Leuk
Lymphoma. 1995 Jun;18(1-2):17-25. Review. PubMed PMID: 8580821.


146: Pileri S, Piccaluga PP, De Vivo A, Sabattini E, Poggi S, Melilli G, Falini
B, Piccaluga A. Malignant lymphomas of the gastro-intestinal tract: a reappraisal
on the basis of the newly proposed Revised European American Lymphoma
Classification. Ital J Gastroenterol. 1994 Oct-Nov;26(8):405-18. Review. PubMed
PMID: 7703515.

Altre pubblicazioni

 

1.       Martinelli G, Piccaluga PP, Malagola M, Soverini S, Rondoni M, Isidori A, Bonifazi F, Giannini B, Grafone T, Ottaviani E, De Vivo A, Bosi C, Bianchini M, Terragna C, Fiacchini M, Ricci P, Visani G, Russo D, Bassi S, Trabacchi E, Rosti G, Buonamici S, Alberti D, Baccarani M. Other targets for Imatinib therapy. Journal on Biotechnology and Molecular Biology 15(1): 64, 2003.

2.       Piccaluga PP, Ricci P, Malagola M, Rondoni M, Vigna E, Bosi C, Gaitani S, Visani G, Martinelli G. Instillazione diretta intranasale di amfotericina B liposomiale nella terapia delle micosi nasali. Farmaci, 27(3): 13-15, 2004.

3.       Vigna E, Placci A, Laterza C, Agostinelli C, Papayannidis C, Martinelli G, Pileri SA, Piccaluga PP. Impiego del pegfilgrastim in associazione cn R-CHOP in un paziente critico affetto da un linfoma non Hodgkin aggressivo primitivo del cuore. Continuing Education in Oncologia, Vol. II:3, 5-7, 2005.

4.       Piccaluga PP, Vigna E, Martinelli G. Fattibilità ed efficacia del regime chemioterapico My-Flaig (mylotarg, fludarabina, citosina arabinsoide, idarubicina e pegfilgrastim) nella terapia della leucemia acuta mieloide. Continuing Education in Oncologia, Vol. II:3, 8-11, 2005.

5.       Piccaluga PP. Leucemia mieloide acuta: razionale e risultati clinici della terapia di salvataggio. Update in Ematologia 2002, Vol. 1: 3-4.

6.       Malagola M, Isidori A, Rondoni M, Piccaluga PP, Martinelli G. Leucemia linfoblastica acuta: identificazione del rischio. Update in Ematologia 2002, Vol. 1: 4-6.

7.       Isidori A, Malagola M, Piccaluga PP, Rondoni M, Martinelli G. Leucemia mieloide acuta: ruolo dei regimi di induzione-consolidamento intensificati in funzione del cariotipo. Update in Ematologia2002, Vol. 1: 8-10.

8.       Coature del libro “Corso di Malattie del Sangue e degli Organi Emopoietici”, Ed Esculapio, Bologna, 2007.

9.       Pileri, S.A., Agostinelli, C., Campidelli, C., Bacci, F., Sabattini, E., Giunti, M., Pileri, A. Jr., Piccioli, M., Righi, S., Rossi, M., Ferri, C., and Piccaluga, P.P.: Chronic inflammation, includine Autoimmunity, and Lymphomagenesis. The lymphoid neoplasms, 3rd Edition. Ian Magrath, Editor. Hodder Headline Group, London. In press.

10. Coature del libro “Corso di Malattie del Sangue e degli Organi Emopoietici”, Ed Esculapio, Bologna, 2007.

11. Coautore del libro "Recommendation of the European Working Group for Adult ALL" , Uni-Med  Verlag AG, Bremen, 2011.